Dear Colleagues,

 

Please consider submitting an abstract for a Special Issue of the Journal of Substance Use & Addiction Treatment (JSAT) on the application of implementation science to the field of addiction treatment (see attachment for full details).

 

Although access to evidence-based addiction treatment services has been a longstanding problem, the current US opioid epidemic has drawn this issue into dire national focus. Despite significant federal investment to curtail overdose mortality, rates continue to rise. Access to proven pharmacological and psychosocial treatments is challenging for many. Implementation science holds the methodological key to address gaps in equitable access to high quality interventions for opioid use disorders and other substance use disorders. A JSAT special issue highlighting new and innovative research in this field will be timely.

 

We invite high-quality manuscripts on addiction treatment implementation research, such as:

 

 

We welcome rigorous quantitative research, rigorous theory-driven or -generating qualitative studies, study protocols, systematic reviews and meta-analyses.

 

Authors should submit an abstract (maximum of one page) of the proposed paper to Dr. Mark McGovern (mpmcg@stanford.edu) by November 1, 2023. Abstracts will be peer-reviewed and decisions will be announced no later than December 15, 2023. Papers invited for submission will be due on April 15, 2024, with publication on a rolling basis through late 2024.

 

Please email any questions to guest editors Mark McGovern (mpmcg@stanford.edu), Heather Gotham (gothamh@stanford.edu), or Helene Chokron Garneau (Helene.chokrongarneau@stanford.edu).

 

We look forward to receiving your abstracts!

 

Thanks, Heather

 

Heather J. Gotham, PhD (she/her)

Co-Director, HEAL Data2Action Research Adoption Support Center (RASC), Administrative Core

Director, Mental Health Technology Transfer Center (MHTTC) Network Coordinating Office (NCO)

Clinical Associate Professor

Center for Dissemination and Implementation (CDI)

Department of Psychiatry & Behavioral Sciences

Stanford University School of Medicine

1070 Arastradero Rd

Palo Alto, CA 94304

650-721-8692

785-218-2919 (direct)

gothamh@stanford.edu